Profile | GDS2987 / GI_34147481-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 235.4 | 85 |
GSM215244 | HMVEC_vehicle_rep2 | 277.2 | 85 |
GSM215253 | HMVEC_vehicle_rep3 | 228.9 | 84 |
GSM215254 | HMVEC_atorvastatin_rep1 | 82.6 | 74 |
GSM215282 | HMVEC_atorvastatin_rep3 | 94.2 | 75 |
GSM215344 | HMVEC_atorvastatin_rep2 | 71.4 | 72 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 216.1 | 83 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 222.9 | 83 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 203.3 | 82 |
GSM215294 | HMVEC_SLx2119_rep1 | 164.1 | 81 |
GSM215295 | HMVEC_SLx2119_rep2 | 173.7 | 80 |
GSM215296 | HMVEC_SLx2119_rep3 | 144.1 | 79 |
GSM215297 | PASMC_vehicle_rep1 | 42.3 | 53 |
GSM215298 | PASMC_vehicle_rep2 | ||
GSM215310 | PASMC_vehicle_rep3 | ||
GSM215311 | PASMC_atorvastatin_rep1 | 32.8 | 50 |
GSM215312 | PASMC_atorvastatin_rep2 | ||
GSM215313 | PASMC_atorvastatin_rep3 | ||
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | ||
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 2.1 | 4 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 6.7 | 12 |
GSM215327 | PASMC_SLx2119_rep1 | 24.3 | 40 |
GSM215328 | PASMC_SLx2119_rep2 | 2.5 | 5 |
GSM215329 | PASMC_SLx2119_rep3 | 54.4 | 66 |
GSM215330 | Fibroblasts_vehicle_rep1 | 405.2 | 88 |
GSM215331 | Fibroblasts_vehicle_rep2 | 431.6 | 88 |
GSM215332 | Fibroblasts_vehicle_rep3 | 377 | 88 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 423.9 | 89 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 396.5 | 87 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 417.4 | 88 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 451.4 | 89 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 433.3 | 89 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 459.6 | 89 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 447.7 | 89 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 466.7 | 89 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 507.2 | 90 |